Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Current Drug Targets|February 3, 2023
Dose-dependent Effects of PRC2 and HDAC Inhibitors on Cardiomyocyte Hypertrophy Induced by PhenylephrineZhenyi Zhao, Jian Lv, Ningning Guo, et al.
European Journal of Pharmacology|April 23, 2020
Identification of cofilin-1 as a novel mediator for the metastatic potentials and chemoresistance of the prostate cancer cellsLiankuai Chen, Jialong Cai, Yishan Huang, et al.
Pharmacological Research|December 6, 2019
FGF9 inhibition by a novel binding peptide has efficacy in gastric and bladder cancer per se and reverses resistance to cisplatinJizhong Wang, Xiangpeng Tan, Qiuxiao Guo, et al.
Frontiers in Cardiovascular Medicine|January 3, 2022
NAP1L5 Promotes Nucleolar Hypertrophy and Is Required for Translation Activation During Cardiomyocyte HypertrophyNingning Guo, Di Zheng, Jiaxin Sun, et al.
Metabolism: Clinical and Experimental|June 15, 2025
NIPSNAP1 and NIPSNAP2 facilitate healthy aging independent of mitophagyJian Lv, Junmei Wang, Qin Chen, et al.
Nucleic Acids Research|September 9, 2025
EZH2 variants derived from cryptic splice sites govern distinct epigenetic patterns during embryonic developmentNingning Guo, Qiuxiao Guo, Hongchao Zhan, et al.
Nature Communications|December 13, 2025
ARMH4 accelerates aging by maintaining a positive-feedback growth signaling circuitYu Fang, Baosen Wang, Qiuxiao Guo, et al.
Nucleic Acids Research|December 10, 2024
Downregulation of MLF1 safeguards cardiomyocytes against senescence-associated chromatin openingJian Lv, Qin Chen, Junmei Wang, et al.
Anti-Cancer Drugs|September 11, 2019
Antitumor effect of a short peptide on p53-null SKOV3 ovarian cancer cellsYi-Shan Huang, Tian-Xiang Wang, Xiao-Mian Lin, et al.
Pageof 1